AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

STRATEC SE

Declaration of Voting Results & Voting Rights Announcements Jan 18, 2018

416_dva_2018-01-18_529e8d84-624f-4b81-9154-511ab7573910.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

News Details

Voting Rights Announcements | 18 January 2018 14:26

STRATEC Biomedical AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical AG

18.01.2018 / 14:26

Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.


Notification of Major Holdings

1. Details of issuerSTRATEC Biomedical AG

Gewerbestr. 37

75217 Birkenfeld

Germany

2. Reason for notification

Acquisition/disposal of shares with voting rights
Acquisition/disposal of instruments
Change of breakdown of voting rights
X Other reason:

Voluntary group notification with triggered threshold on subsidiary level due to internal reorganisations

3. Details of person subject to the notification obligation

Name: City and country of registered office:
Allianz SE Munich

Germany

4. Names of shareholder(s)

holding directly 3% or more voting rights, if different from 3.

Allianz I.A.R.D. S.A.

5. Date on which threshold was crossed or reached:21 Dec 2017

6. Total positions

% of voting rights attached to shares

(total of 7.a.)
% of voting rights through instruments

(total of 7.b.1 + 7.b.2)
total of both in %

(7.a. + 7.b.)
total number of voting rights of issuer
Resulting situation 5.14 % 0 % 5.14 % 11920945
Previous notification 5.11 % n/a % n/a % /

7. Notified details of the resulting situation

a. Voting rights attached to shares (Sec.s 33, 34 WpHG)

ISIN absolute in %
direct

(Sec. 33 WpHG)
indirect

(Sec. 34 WpHG)
direct

(Sec. 33 WpHG)
indirect

(Sec. 34 WpHG)
DE000STRA555 0 612492 0 % 5.14 %
Total 612492 5.14 %

b.1. Instruments according to Sec. 38 para. 1 No. 1 WpHG

Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
%
Total %

b.2. Instruments according to Sec. 38 para. 1 No. 2 WpHG

Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
%
Total %

8. Information in relation to the person subject to the notification obligation

Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more)
Allianz SE % % %
Allianz Argos 14 GmbH % % %
Allianz Holding France SAS % % %
Allianz France S.A. % % %
Allianz I.A.R.D. S.A. 5.03 % % 5.03 %
Allianz SE % % %
Allianz Asset Management GmbH % % %
Allianz Global Investors GmbH % % %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG

Date of general meeting:
Holding position after general meeting: % (equals voting rights)

10. Other explanatory remarks:


18.01.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de


Language: English
Company: STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Germany
Internet: www.stratec.com
End of News DGAP News Service

show this

Talk to a Data Expert

Have a question? We'll get back to you promptly.